Clinical Characteristics, Treatments, and Outcomes of MI Patients Presenting With Normal ECG

NCT ID: NCT04710446

Last Updated: 2022-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-01

Study Completion Date

2023-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the investigators aimed to analyzed data for hospitalized MI patients with normal ECG.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The electrocardiogram (ECG) at presentation is a useful tool for risk prediction. Patients with ACS(Acute Coronary Syndromes) and ST-segment depression on ECG have a worse prognosis than patients with a normal ECG. ST-segment depression is not only a qualitative marker, but also a quantitative marker of risk, because the number of leads with ST-segment depression and the magnitude of ST-segment depression (either within a single lead or as sum over all leads) are indicative of the extent of ischaemia and correlate with prognosis.The presence of ST-segment depression \>1 mm in \>\_6 leads in conjunction with ST-segment elevation in aVR and/or V1, particularly if the patient presents with haemodynamic compromise, suggests multivessel ischaemia or severe left main coronary artery stenosis. However,in patients presenting without persistent ST-segment elevation,the clinical features, treatments, and outcomes in patients with normal ECG is still unclear.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-ST Elevated Myocardial Infarction Electrocardiography

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NSTEMI Patients presenting with normal ECG

NSTEMI Patients presenting with normal ECG

No interventions assigned to this group

NSTEMI Patients presenting with isolated T wave inversion

NSTEMI Patients presenting with isolated T wave inversion

No interventions assigned to this group

NSTEMI Patients presenting with transient ST-segment elevation

NSTEMI Patients presenting with transient ST-segment elevation

No interventions assigned to this group

NSTEMI Patients presenting with resting U wave inversion

NSTEMI Patients presenting with resting U wave inversion

No interventions assigned to this group

NSTEMI Patients presenting with low QRS voltage

NSTEMI Patients presenting with low QRS voltage

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Inclusion Criteria:all patients hospitalized with a principal diagnosis of non-ST-segment elevation infarction (NSTEMI) according to the current ACC/AHA guidelines.

exclusion criteria: end-stage organic disease, thrombotic hematological disorders, and poor echogenicity
Minimum Eligible Age

20 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Henan Provincial People's Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

yansheng Huang

Role: STUDY_DIRECTOR

Henan Provincial People's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Henan province people's hospital

Zhengzhou, Henan, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

qiongya Guo

Role: CONTACT

18838067197

minghu Zhao

Role: CONTACT

13603996609

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

yansheng Huang

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Normal MI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.